Armed With $10M in Funding, Phosphorus Plans to Expand Genetic Testing, Bioinformatics Footprint | GenomeWeb

NEW YORK (GenomeWeb) – Newly minted computational genomics firm Phosphorus is hoping to build its business around bioinformatics solutions that support genetic testing laboratories as well as clinical tests for identifying patients' predispositions to cardiovascular disease and other conditions.

The company is preparing to launch two new genetic tests in 2017 and helping a number of unnamed clinical labs implement its lab management and variant analysis and reporting software, Phosphorus Founder and CEO Alexander Bisignano told GenomeWeb this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.